Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA 2004

Integrated Approaches to Drug Discovery & Development:
Turning Measurements to Medicine

October 18 - 21, 2004

CPSA Digest 2004

Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2004 Sponsors


CPSA 2004 Sponsors

Thermo Electron Ad
Thermo Electron
New Objective, Inc.
New
Objective


Advanced Chemistry
Advanced
Chemistry
Development
Tandem Labs
Tandem
Labs


Waters
Waters
Applied Biosystems
Applied
Biosystems


McKinley Scientific
McKinley
Scientific
Agilent
Agilent

CPSA Digest Archive
CPSA Digest 2000
CPSA Digest 2001
CPSA Digest 2002
CPSA Digest 2003
CPSA Digest 2004 >>


Overview | Short Courses | Program | Poster Abstracts | Sponsors

Proceedings

Day 1 - Monday, October 19, 2004



Overview

Objectives, Format & Opening Remarks

Steven A. Hofstadler, Ibis Therapeutics
Mark Sanders, Bristol-Myers Squibb



Plenary

Quantitative and Ultra-sensitive High Throughput Proteomics

Richard D. Smith, Pacific Northwest National Laboratory

Roundtable Discussion



Biomarkers - Initiatives, Perspectives & Approaches

Discussion Leaders: Bradley L. Ackermann, Eli Lilly and Company
Sushmita M. Roy, SurroMed


An Industrial Perspective on Biomarker Research: One Approach Taken

Stanley Hefta, Bristol-Myers Squibb

Biomarkers of Oxidative Stress

Ian Blair, University of Pennsylvania


Roundtable Discussion

How to We Set Priorities in Drug Discovery and Development

Discussion Leader: Mike S. Lee, Milestone Development Services

Bradley Ackermann, Eli Lilly and Co.
Edward Brewer, Tandem Labs
Chandra Natarajan, Sanofi Aventis
Steve Unger, Bristol-Myers Squibb



Outsourcing Trends -
Emerging Business Models & Overseas Partners

Discussion Leader: Roger Hayes, Schering Plough Research Institute

The Impact of Value Enhancement Initiatives to Outsourcing Strategies

Roger Hayes, Schering Plough Research Institute

Outsourcing and Offshoring DMPK Studies - The Pros and Cons

Zamas Lam, Quest Pharmaceutical Services

Cost Benefit Analysis

Mickey O'Brien, Tandem Labs

Roundtable Discussion



High Throughput Analysis & Information Management Strategies

Discussion Leader: Eric A. Milgram, Advanced Chemistry Development

Flexible Automation Tools for Drug Metabolism: Workstation and Fully
Automated Approaches for in vitro and PK Studies

Tom Lloyd, H. Kandoussi and R. Talaat, Wyeth

Automatic Reduction of Analytical Data System

Kenneth Lewis, Eli Lilly and Company

High-Throughput LC-MS – A Total Package

Manish Soni, Aventis Pharmaceuticals

Roundtable Discussion



Vendor/Exhibitor Sessions:

Discussion Leader: Kathleen Anderson, Novatia


Poster Sessions

Chairs:
Praveen Balimane, Bristol-Myers Squibb
Manish Soni, Aventis Pharmaceuticals
James Stephenson, Research Triangle Institute




overview | training | workshops | consulting | symposia | contact | home